These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 18210813

  • 1. [Pathogenic mechanisms of myasthenia gravis induced by antibodies against muscle-specific kinase].
    Maruyama N, Shigemoto K.
    Rinsho Shinkeigaku; 2007 Nov; 47(11):842-4. PubMed ID: 18210813
    [Abstract] [Full Text] [Related]

  • 2. Myasthenia gravis experimentally induced with muscle-specific kinase.
    Shigemoto K, Kubo S, Jie C, Hato N, Abe Y, Ueda N, Kobayashi N, Kameda K, Mominoki K, Miyazawa A, Ishigami A, Matsuda S, Maruyama N.
    Ann N Y Acad Sci; 2008 Nov; 1132():93-8. PubMed ID: 18096854
    [Abstract] [Full Text] [Related]

  • 3. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN, Reddel SW, Gervásio OL, Phillips WD.
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [Abstract] [Full Text] [Related]

  • 4. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
    Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A.
    Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects.
    Viegas S, Jacobson L, Waters P, Cossins J, Jacob S, Leite MI, Webster R, Vincent A.
    Exp Neurol; 2012 Apr; 234(2):506-12. PubMed ID: 22326541
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Divalent and monovalent autoantibodies cause dysfunction of MuSK by distinct mechanisms in a rabbit model of myasthenia gravis.
    Mori S, Yamada S, Kubo S, Chen J, Matsuda S, Shudou M, Maruyama N, Shigemoto K.
    J Neuroimmunol; 2012 Mar; 244(1-2):1-7. PubMed ID: 22222307
    [Abstract] [Full Text] [Related]

  • 10. Myasthenia gravis patients with anti-MuSK antibodies.
    Zagar M, Vranjes D, Sostarko M, Vogrinc Z, Bilić E, Trbojević Cepe M.
    Coll Antropol; 2009 Dec; 33(4):1151-4. PubMed ID: 20102061
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A, Tonali PA, Padua L, Monaco ML, Scuderi F, Batocchi AP, Marino M, Bartoccioni E.
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Seronegative myasthenia gravis.
    Vincent A, McConville J, Farrugia ME, Newsom-Davis J.
    Semin Neurol; 2004 Mar; 24(1):125-33. PubMed ID: 15229799
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.